| 2014 | MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. | Thirumurthi, U; Shen, J; Xia, W; LaBaff, AM; Wei, Y; Li, CW; Chang, WC; Chen, CH; Lin, HK; Yu, D; Hung, MC | Science signaling 7(336), ra71 | | | |
| 2015 | Novel Cancer Therapeutics with Allosteric modulation of the mitochondrial c-Raf-DAPK complex by Raf inhibitor combination therapy. | Tsai, YT; Chuang, MJ; Tang, SH; Wu, ST; Chen, YC; Sun, GH; Hsiao, PW ; Huang, SM; Lee, HJ; Yu, CP; Ho, JY; Lin, HK; Chen, MR; Lin, CC; Chang, SY; Lin, VC; Yu, DS; Cha, TL | Cancer Research 75(17), 3568-3582 | | | |
